BCG Immunotherapy as a Systemic Adjunct to Surgery in Malignant Melanoma
- 1 May 1976
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 60 (3) , 431-439
- https://doi.org/10.1016/s0025-7125(16)31890-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-GuérinNew England Journal of Medicine, 1974
- Complications of BCG Immunotherapy in Patients with CancerNew England Journal of Medicine, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Immunological Aspects of Neoplasia: A Rational Basis for ImmunotherapyAnnals of Internal Medicine, 1971
- Demonstration of cell‐mediated immunity to human neoplasms of various histological typesInternational Journal of Cancer, 1971
- Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the DiseaseBMJ, 1969
- Detection by immunofluorescenge of antibodies specific for human malignant melanoma cellsCancer, 1969